DXCM vs INNV · P/E 63, rev $2.50B vs rev $853.7M
DexCom Inc (DXCM) versus InnovAge Holding Corp (INNV) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
InnovAge Holding Corp (INNV) is a medical care facilities company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported INNV revenue for 2025-06-30 was $853.7M. Net income was -$35.3M. INNV currently screens at market cap $990.9M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. INNV currently screens at market cap $990.9M.
Not investment advice. Open the DXCM and INNV stock pages for the full models.
Not investment advice.